Arrowstreet Capital
CLDX icon

Arrowstreet Capital’s Celldex Therapeutics CLDX Stock Holding History

Arrowstreet Capital’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,356
Closed -$2.4M – 1471
2021
Q3 		$2.4M Buy
+44,356
New +$2.08M ﹤0.01% 1092
2016
Q4 		– Sell
-18,329
Closed -$1.11M – 1769
2016
Q3 		$1.11M Buy
+18,329
New +$1.14M ﹤0.01% 1053
2014
Q2 		– Sell
-7,958
Closed -$2.11M – 1006
2014
Q1 		$2.11M Sell
7,958
-23,827
-75% -$9.12M 0.01% 647
2013
Q4 		$11.5M Buy
+31,785
New +$12.2M 0.06% 267

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return